A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 9PM EDT 4 min · 25 Sep 2026 · NPR News Now

HAIR IDEAS THAT ARE SO COOL || Easy Hair Tips And DIY Tricks by 123 GO! 11 min · 25 Sep 2026 · 123 GO!

OTHER PEOPLE VS ME || Funny Relatable Situations and Fails by 123 GO! 11 min · 25 Sep 2026 · 123 GO!

FUNNY LONG, SHORT AND CURLY HAIR PROBLEMS || Relatable Situations And Fails by 123 GO! 11 min · 25 Sep 2026 · 123 GO!

NHL Pacific Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 8PM EDT 4 min · 25 Sep 2026 · NPR News Now

Report any issue

Source

Recorded21 Dec 2023

Publisherfeeds.transistor.fm ↗

Handlerec:11741991

Show notes

In this week's episode we’ll discuss the findings from a natural history study of patients with familial platelet disorder with myeloid malignancy, learn more about the role of HEXIM1 as an essential transcription regulator in human erythropoiesis, and discuss the utility of residual disease as a predictor of relapse in CML patients stopping TKI therapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in